ETHICAL PRINCIPLES
European Annals of Dental Sciences adopts the principles and standards set by the International Committee of Medical Journal Editors (ICMJE) and the Committee on Publication Ethics (COPE). We advise all our stakeholders to follow ICMJE and COPE guidelines within the framework of academic and ethical rules.
Actions Contrary to Scientific Research and Publication Ethics
a) Plagiarism: Presenting the original ideas, methods, data or works of others as one's own work in whole or in part without citation in accordance with scientific rules,
b) Forgery: Using non-existent or falsified data in scientific research,
c) Distortion: Falsifying research records or data obtained, falsifying devices or materials not used in the research, falsifying or shaping the results of the research in line with the interests of the persons and organizations receiving support,
d) Republishing: Presenting duplicate publications as separate publications for academic appointments and promotions,
e) Slicing: Dividing the results of a research into parts in a way that disrupts the integrity of the research and inappropriately and publishing them in more than one number and presenting these publications as separate publications in academic appointments and promotions,
f) Unfair authorship: Including or excluding people who have not actively contributed, changing the author ranking in an unjustified and inappropriate manner, removing the names of active contributors from the work in subsequent editions, using one's influence to have one's name included among the authors even though one has not actively contributed,
Other types of ethical violations are as follows
a) Failing to specify the persons, institutions or organizations providing support and their contributions in publications resulting from research conducted with support,
b) Using theses or studies that have not yet been submitted or defended and accepted as a source without the permission of the owner,
c) Failure to comply with ethical rules in research on humans and animals, and failure to respect patient rights in publications,
d) Violating the provisions of the relevant legislation in human biomedical research and other clinical research,
e) Sharing the information contained in a work that he/she has been assigned to examine with others before publication without the express permission of the author,
f) To misuse the resources, spaces, facilities and devices provided or allocated for scientific research,
g) Making baseless, unwarranted and intentional allegations of ethical violations,
h) Publishing data obtained in surveys and attitude surveys conducted within the scope of a scientific study without obtaining the explicit consent of the participants or, if the research is to be conducted in an institution, without obtaining the permission of the institution,
i) To harm animal health and ecological balance in research and experiments,
j) Failure to obtain the necessary permissions in writing from the authorized units in research and experiments before starting the studies.
k) Conducting research and experiments in violation of the provisions of the legislation or international conventions to which Turkey is a party regarding the relevant research and experiments.
l) Failure by researchers and authorities to comply with the obligation to inform and warn those concerned about possible harmful practices related to the scientific research conducted,
m) Not using the data and information obtained from other persons and institutions in scientific studies to the extent and in the manner permitted, not respecting the confidentiality of this information and not ensuring its protection,
n) Making false or misleading statements regarding scientific research and publications in academic appointments and promotions,
Human and animal experiments
For original research manuscripts reporting experiments on animals, the corresponding author must confirm that all experiments were performed in accordance with relevant guidelines and regulations. The manuscript must include a statement identifying the institutional and/or licensing committee approving the experiments, including any relevant details regarding animal welfare, patient anonymity, drug side effects, and informed consent.
For experiments involving human subjects, authors must identify the committee (e.g., Institutional Review Board [IRB]) approving the experiments and include with their submission a statement confirming that informed consent was obtained from all subjects. All human studies must adhere to the principles set out in the Declaration of Helsinki. Scientific research on animals must be conducted in accordance with the ARRIVE guidelines and approval must be obtained from the relevant ethics committee. In addition, the consent of the legal guardian of children, wards or persons with certified mental illness must be obtained.
It is the author’s responsibility to ensure that a patient’s anonymity be carefully protected and to verify that any experimental investigation with human subjects reported in the manuscript was performed with informed consent and following all the guidelines for experimental investigation with human subjects required by the institution(s) with which all the authors are affiliated. All identifying details (patient names and/or initials and name of specific hospital unit) should be removed from the text, tables, and/or radiographs or other figures. Patients should be assigned numbers instead. Identifying data should be removed from a manuscript unless important clinically or epidemiologically. Clinically and epidemiologically significant details include: race, sex, age, occupation, country or region of origin, and/or sexual orientation. Note that the same information must be given for each patient or group. If any individual data is included, written consent for participation/publication must be given for each patient or group.
If any individual data is included (i.e., an identifiable full-face picture in a clinical report), written consent for participation/publication must be obtained from every individual whose data is included. A written statement attesting that the author has received and archived such written patient consent must accompany the manuscript. For research articles, if authors cannot obtain consent to publish individual data, they may only provide summary results. Exclusions to this include:
• The patients are de-identified
• The patients are dead
• There has been a waiver granted by the Institutional Review Board (IRB).
Permissions Form: If identifying details must be retained, the author must attest they have informed consent from the patients (a signed permissions form), see Appendix A below.
Permissions must appear in English. In the case of a non-English speaking patient/author the
permission should appear first in the native language with the translation to English below and the signature following both. If the patient cannot be located or refuses to consent to publication, the manuscript will NOT be published. In the event that the patient cannot provide consent due to death or legal incompetency (this includes photos of corpses) permission from the power of attorney is needed as well as proof of power of attorney. If the patient is a minor, a legal guardian must provide permission. Previous publication of news coverage does NOT eliminate a patient’s right to privacy and does NOT negate the need for patient permission. This informed consent should be indicated in the text of the article (in the Methods section, if appropriate) or in the Acknowledgments at the end of the article. Permissions forms should be uploaded at the time of submission. Articles will not be reviewed until permissions forms are submitted.
Ethics Committee Approval
Our journal requires that the relevant ethics committee decision must be obtained for all studies in all disciplines that require ethics committee approval. In this context, authors should write the date and number of Ethics Committee approval in the “Sampling and Methods/ Materials and Methods” section. In case presentations, the information that the informed consent form has been obtained must be included in the article.
In line with the regulations implemented by Ulakbim TR Index since 2020, studies that do not have ethics committee permission are not evaluated in our journal.
Studies Requiring Ethics Committee Approval
In our journal, researches that require ethics committee permission include the following studies:
• All research conducted with qualitative or quantitative approaches that involve collecting data from participants through methods such as surveys, interviews, focus groups, observations, experiments and interview techniques,
• Studies in which humans and animals (including materials or data) are used for experimental or other scientific purposes,
• Clinical trials conducted on humans,
• Scientific research on animals,
• Retrospective studies within the framework of the Personal Data Protection Law.
In order for such studies to be included in the evaluation, the relevant ethics committee permissions must be obtained and these permissions must be clearly stated in the text of the article.
NOTE: Scientific research on humans and animals must be conducted in accordance with the Declaration of Helsinki and ARRIVE guidelines and approval must be obtained from the relevant ethics committee. Studies without ethics committee approval are not evaluated in our journal.
Clinical Research Policy
Our journal requires that clinical research involving human participants be conducted in accordance with ethical principles, standards of scientific integrity, and internationally accepted publishing practices. All clinical research submitted to the journal is expected to comply with the International Committee of Medical Journal Editors (ICMJE) Recommendations, including the ICMJE Clinical Trial Registration Policy (1).
Clinical Trial Registration
Prospectively planned interventional clinical trials involving human participants must be registered in a publicly accessible and internationally recognized clinical trial registry before the enrollment of the first participant.
At the time of submission, authors must provide:
• Name of the clinical trial registry;
• Registration number; and
• Registration date.
Accepted trial registries include ClinicalTrials.gov, ISRCTN Registry, EU Clinical Trials Information System (CTIS), Australian New Zealand Clinical Trials Registry (ANZCTR), and other registries recognized by the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP).
Reporting Standards
Randomized controlled clinical trials should be reported in accordance with the CONSORT (Consolidated Standards of Reporting Trials) Statement. Where appropriate, the Editors may request submission of the CONSORT Checklist and CONSORT Flow Diagram during the manuscript submission process.
Editorial Authority
The Editors reserve the right to request documentation, including clinical trial registration records, ethics committee approval, informed consent statements, or other supporting documents, to verify the ethical and scientific integrity of submitted clinical research. Failure to provide the requested documentation or evidence of non-compliance with internationally accepted ethical standards may result in rejection of the manuscript or termination of the review process.
Principles of Research Ethics
• All research involving human participants must be conducted in accordance with the ethical principles set forth in the Declaration of Helsinki. For research requiring ethics committee approval, approval must be obtained from the relevant ethics committee, and the name of the ethics committee, the approval date, and the decision/protocol number must be clearly stated in the article.
• In all research involving human participants, written informed consent must be obtained from the participants or their legal representatives prior to their participation in the study. Participants must be informed about the purpose of the study, the methodology, the potential benefits, the risks, and their right to withdraw from the study at any time without providing a reason.
• Experimental studies conducted on animals must be carried out in accordance with the principles of the ARRIVE Guidelines. National and international ethical standards regarding the protection of animal welfare must also be observed.
• In research involving biological samples, clinical data, or personal health data obtained from humans, participants’ privacy must be protected; personal data must be processed in accordance with applicable data protection laws, and published studies must not contain any identifiable information.
• Scientific integrity, accuracy, transparency, impartiality, and research integrity must be adopted as fundamental principles throughout the planning, conduct, data collection, analysis, and reporting of research. Data fabrication, data manipulation, selective reporting, or other violations of scientific ethics are unacceptable.
• Data obtained during the research process must be recorded accurately, completely, and verifiably; the editorial board may request approval from an ethics committee, informed consent forms, or other supporting documents related to the research when deemed necessary.
• Participation in research must be entirely voluntary. Participants must not be subjected to any pressure, coercion, or inappropriate inducement; they must be able to withdraw from the study at any time without suffering any loss of rights.
• In research involving children, individuals with limited decision-making capacity, or other vulnerable groups, the principles established by the relevant ethics committee must be followed; where necessary, permission must be obtained from legal guardians, and the rights and safety of participants must be prioritized.
• Researchers must clearly disclose any conflicts of interest that could influence the design, conduct, analysis, or interpretation of the research results; funding sources, sponsorships, and institutional support, if any, must be disclosed transparently.
• If permission from the relevant institution, organization, or healthcare facility is required to conduct the research, the necessary administrative approvals must be obtained before the research begins. The editorial board may request documentation regarding these approvals when deemed necessary.
Use of Artificial Intelligence
• Our journal permits the use of artificial intelligence (AI) and AI-supported technologies during the article preparation process, provided that such use complies with the principles of scientific integrity and publication ethics.
• AI tools may be used in processes that do not affect the scientific originality of the article, such as language editing, spelling and grammar checks, improving text readability, or literature reviews. However, AI must not be used for purposes that could affect scientific outcomes, such as research design, data generation, data fabrication, data manipulation, alteration of statistical results, image generation, or the interpretation of research findings.
• AI tools cannot be listed as authors and cannot assume authorship responsibility. The authors are fully responsible for the content, accuracy, originality, and compliance with ethical principles of the article, as well as for the proper disclosure of all AI tools used.
• If AI tools are used during the preparation of the article, the name of the tool, its version (if applicable), the purpose of its use, and the stage at which it was used must be reported to the editorial office at the time of submission and, if necessary, included in the article as an appropriate disclosure.
• The editorial board reserves the right to request additional clarification or supporting information regarding the use of artificial intelligence. If the use of artificial intelligence is found to violate ethical principles, the article may be rejected, the review process may be terminated, or necessary editorial actions may be taken for published articles.
• Reviewers must not use AI tools during the review process in a manner that violates the confidentiality of the peer review process. Manuscripts submitted for review or their contents must not be uploaded to or shared with generative AI systems without the editorial office’s permission. Reviewer evaluations must be based on the reviewer’s own scientific expertise and independent judgment.
Conflicts of interest
Authors are required to disclose any possible conflicts of interest. These include, for example, patent, ownership, employment, stock ownership, consultancies, speaker's fee. Author's conflict of interest (or information specifying the absence of conflicts of interest) will be included on the title page of published articles. Our journal guarantees the independent and impartial completion of the publication process, taking into account the conflicts of interest between the author(s), reviewers and other editors. Our journal acts in accordance with COPE flowcharts (1,2) regarding potential conflicts of interest.
Relations with the Journal Owner and Publisher
The relationship between the editor and the publisher is based on the principle of editorial independence. In accordance with the written contract between the editor and the publisher, all editorial decisions are independent of the publisher and the journal owner.
Protection of Intellectual Property Rights
Our journal is obliged to protect the intellectual property rights of all published articles and to defend the rights of the journal and the author(s) in possible violations.
Protection of Personal Data of Participants
All personal data sent to our journal are protected in accordance with legal regulations and ethical rules.
Complaints
The editor/editorial board carefully examines the complaints received from authors, reviewers or readers and tries to respond in an explanatory manner. Complaints should be sent directly to bezgin@dentistry.ankara.edu.tr. The editor follows the procedure outlined in the COPE flowcharts (1,2) regarding complaints.
Authorship
Requirements for all categories of articles largely conform to the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals,” developed by the ICMJE. A manuscript will be considered for publication with the understanding that:
• all named authors have agreed to its submission
• it is not currently being considered for publication by another journal
• if the paper is accepted, it/ a part of it will not subsequently be published in the same or similar form in any language without the consent of publisher.
Each author must have contributed sufficiently to the intellectual content of the submission. Any changes to the author list after submission, such as a change in the order of the authors, or the deletion or addition of authors, will follow the guidelines as set out by COPE (1, 2, 3, 4, 5). The corresponding author must confirm that she or he has had full access to the data in the study and final responsibility for the decision to submit for publication. The ICMJE recommends that authorship be based on the following 4 criteria:
1. Substantial contributions to the conception or design or the work; or the acquisition, analysis, or interpretation of data for the work; AND
2. Drafting the work or revising it critically for important intellectual content; AND
3. Final approval of the version to be published; AND
4. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
In addition to being accountable for the parts of the work she or he has done, an author should be able to identify which co-authors are responsible for specific other parts of the work. In addition, authors should have confidence in the integrity of the contributions of their co- authors.
When a large multi-author group has conducted the work, the group ideally should decide who will be an author before the work is started and confirm who is an author before submitting the manuscript for publication. All members of the group named as authors should meet all four criteria for authorship, including approval of the final manuscript, and they should be able to take public responsibility for the work and should have full confidence in the accuracy and integrity of the work of other group authors.
Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship. All persons designated as authors should qualify for authorship, and all those who qualify should be listed. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.
Contributions by individuals who made direct contributions to the work but do not meet all of the above criteria should be noted in the Acknowledgments section of the manuscript. Examples include: a statistician who has consulted on the included statistical tests; a colleague who has edited the document for English clarity, but did not contribute to the content; a photographer or artist who prepared the figures; a dental technician or assistant who was invaluable to the care of the patient being reported on.
Medical writers and industry employees can be contributors. Their roles, affiliations, and potential conflicts of interest should be included in the author list or noted in the Acknowledgments with their contribution to the work submitted. Failure to acknowledge these contributors can be considered inappropriate. Contributions of authors must be stated at the end of the manuscript.
Plagiarism Check
Submitted manuscripts are evaluated via the iThenticate Professional Plagiarism Prevention program and Intihal.net.
If the editorial board of the European Annals of Dental Sciences suspects a case of plagiarism, we will first contact the authors for clarification. If the authors are unable to sufficiently explain the potential plagiarism, we reserve the right to inform the authors' institutions and funding agencies. If a published article is suspected of plagiarism, we will take the further step of informing our readers, potentially via retraction of the article.
Our journal also takes into account the COPE principles (Plagiarism in a submitted manuscript - Plagiarism in a published article) if plagiarism is detected in a submitted or published article.
Retraction policy
In the unfortunate event an article published in the European Annals of Dental Sciences needs to be retracted, we will follow the COPE flowcharts (1,2,3,4). Potential reasons for retraction include plagiarism, redundant publication, or unreliable results (either through error or misconduct).
Corrections policy
If authors or readers note an error in a published article, they may contact the editorial office. If the correction is minor (i.e., the institution of an author should be changed, or there was a typographical error), the European Annals of Dental Sciences will publish an error notice at the Editor-in- Chief’s discretion. If the error is major (i.e., tests were incorrectly conducted, previously published work was mis-interpreted), please submit a letter to the editor outlining the potential errors. Such errors could potentially lead to the article being retracted. Our journal follows the COPE guidelines (1, 2, 3,) for corrections.
Responsibilities of Editors
Editor-in-Chief is responsible for making the final decision on the status of papers submitted to the journal and has full authority over the editorial content and the timing of publication. She/he is expected to cooperate in any legal investigation including, but not limited to, insult, defamation, copyright infringement, plagiarism regarding the content of the journal. Editorial decisions should not be affected by the origins of the manuscript, including the nationality, ethnicity, political beliefs, race, or religion of the authors. Editing and/or publishing decisions should not be determined by the policies of governments or other agencies outside of the journal itself. Any information regarding a properly submitted paper/manuscript/document is confidential and should not be shared with anyone other than the corresponding author(s), reviewer(s), potential reviewer(s), editorial board member(s), and the publisher(s). Materials and/or data included in the rejected documents or which are under review cannot be used for Editor-in-Chief’s or Editorial Board members’ own research. Editor-in-Chief should obtain necessary disclosure and conflict of interest statements from the author(s). Editors should avoid conflicts of interest. If she/he participates in a scientific debate within his/her journal, she/he should arrange for some other qualified person to take editorial responsibility. Editor-in-Chief should protect the integrity of the published records by issuing corrections and retractions when needed and pursuing suspected or alleged research and publication misconduct. An editor should take necessary measures when ethical complaints have been presented concerning a published paper, in conjunction with the publisher.
Responsibilities of Reviewers
This journal use double blind independent peer-review system. Reviewers contribute to the editorial process by assisting authors to improve their work and by providing their opinion on the suitability of the papers for publication in a timely manner. Reviewers should promptly notify the Editor-in-Chief and excuse themselves from the process if they will not be able to complete the review by the time frame agreed upon or think that they are not qualified to provide suggestions. A manuscript sent for evaluation should be treated as a confidential document and its content should not be discussed with others. Reviewers should not seek the identity of the authors. Reviewers cannot use the information they gained by reviewing a manuscript for their own research purposes until it is published. Reviewers should provide their objective criticism based on scientifically and/or logically proven background. Personal comments are not appropriate. All comments and/or questions directed to the authors should be stated clearly and concisely. Reviewers should be alert for inadequate citation of previous work and similarity between the manuscript under consideration and published papers. In order to avoid any potential conflict of interest, reviewers should immediately contact the Editor-in-Chief and refuse to take part in the editorial process if the manuscript they agreed to examine is closely related to their ongoing research projects which can result in competitive, collaborative, or other relationships/connection with the authors.
Responsibilities of Authors
Authors are responsible for the accuracy of their research as well as its objective and comprehensible presentation. All necessary data, technical details and references should be included in the submission to ensure reproducibility. Fraudulent or knowingly inaccurate statements are not acceptable. Raw data of the research should be kept available and easily accessible, as the authors may be asked to provide additional information during and after the editorial process. All submitted documents should present the result of an entirely original work done by author(s). If the author(s) has/have used the work and/or words of others, these should be properly cited and/or quoted. Manuscripts describing essentially the same research should not be submitted to more than one journal. Submitting the same manuscript to more than one journal concurrently constitutes unethical publishing behavior and must be avoided at all times. Ethical approvals and/or written consents for research studies involving animal or human subjects should have been properly obtained before the experiments and necessary details such as the name of the organization which has granted the approval and project number should be mentioned in the manuscript. All authors should disclose their source of funding and/or financial support for their projects that might be perceived as potential conflict of interest. Authorship should be limited to person(s) who had significantly contributed to the conception, design, execution and interpretation of the project. All those who have made significant contributions should be listed as co-authors. Other persons who are not qualified as authors but have had significant contribution should be acknowledged or listed. It is the responsibility of the corresponding author to ensure that all authors have seen and approved the final version of the manuscript for submission. If an author discovers a significant error and inaccuracy in her/his published work and/or submitted manuscript, it is her/his responsibility to immediately notify the Editor-in-Chief and cooperate in the retraction or correction process of the paper.
PUBLICATION POLICIES
General Principles
• European Annals of Dental Sciences is the official peer-reviewed scientific publication of the Ankara University Faculty of Dentistry. It is a continuously updated, international open access title that publishes scholarly articles written in English. Our scope spans the broad spectrum of dental, oral, and facial health, emphasizing the propagation of novel and pertinent information that is directly applicable to both research and practice. The journal invites original scientific articles, clinical reports, and systematic reviews that contribute significantly to the existing knowledge base.
• The European Annals of Dental Sciences (EADS) is an international scientific journal dedicated to the advancement of research in the fields of dentistry, oral surgery, and medicine. Our principal aim is to foster and promote quality research in these disciplines, with an overarching commitment to contributing to the continuous development of academic, scientific, and social discourse.
• The readership of the European Annals of Dental Sciences is diverse, including researchers, academicians, practicing clinicians, dental surgeons, oral health professionals, postgraduate students, and health policy makers. The journal appeals to individuals seeking to stay abreast of the latest developments and innovations in dentistry, oral surgery, and associated medical fields. Its in-depth and evidence-based content serves as a reliable resource for professionals aiming to improve their practice and for researchers keen on enhancing their understanding of current trends and future directions in these domains.
• Manuscripts must not have been previously published or submitted for publication elsewhere. Manuscripts submitted to our journal are evaluated by at least two independent reviewers within the scope of double blind review. Our journal accepts articles continuously and there is no time limit for article submission. Click here for detailed information about the article evaluation process.
• The authors own the copyright of their works published in our journal and their works are licensed as CC BY-NC 4.0. Articles published in our journal are published as open access under the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) license. Click here for detailed information.
• Articles published in our journal are digitally archived in LOCKSS and DSpace. Articles published in our journal can be accessed free of charge at https://dergipark.org.tr/en/pub/eads/archive. Click here for detailed information.
Special Issue Policy
With the decision of the Editorial Board, a special issue may be published once a year. For articles to be published in the special issue, the publication and evaluation principles are applied as applied in the planned issues.
1- Volume: 51 Issue: Suppl 1 (UDEG 2nd INTERNATIONAL DENTISTRY EDUCATION MEETING)
Our journal, “UDEG 2nd INTERNATIONAL DENTISTRY EDUCATION MEETING” was made available to our readers on 12/31/2024. This issue It was published under the editorship of Prof. Dr. Tuğba BEZGİN. Please click here to reach our special issue. Click here to view the editorial boards for this issue.
2- Volume: 50 Issue: Suppl 1 (International Congress of Oral Diagnosis and Maxillofacial Radiology Society Congress)
Our journal, “International Congress of Oral Diagnosis and Maxillofacial Radiology Society Congress” was made available to our readers on 12/6/2023. This issue It was published under the editorship of Prof. Dr. Tuğba BEZGİN. Please click here to reach our special issue. To access the editorial boards for our issue, please review the complete issue file for our special issue.
3- Volume: 49 Issue: Suppl 1 (1st International Turkish-Japanese Dental Congress)
Our journal, “Volume: 49 Issue: Suppl 1” was made available to our readers on 8/31/2022. This issue It was published under the editorship of Prof. Dr. Tuğba BEZGİN. Please click here to reach our special issue. To access the editorial boards for our issue, please review the complete issue file for our special issue.
4-Volume: 48 Issue: Suppl 1 (1.DECON International Dental Education Congress)
Our journal, “1.DECON International Dental Education Congress” was made available to our readers on 12/1/2021. This issue It was published under the editorship of Prof. Dr. Tuğba BEZGİN. Please click here to reach our special issue. To access the editorial boards for our issue, please review the complete issue file for our special issue.
Price Policy
Article submission, evaluation and publication processes in our journal are completely free of charge. No fee is charged for articles submitted or accepted for publication. In accordance with our publication policy, sponsorship and advertising are not accepted and all expenses of our journal are covered by Ankara University.
August 30, 2026
Page
49-58
